2021 Genomics of ASD: Pathways to Genetic Therapies – Request for Applications

Grants awarded through this RFA are intended to advance the understanding of the genetic basis of ASD and the molecular and cellular consequences of genetic risk, and to provide a foundation for the development of treatments for select genetically defined forms of the condition.

Specificaly, this RFA seeks proposals in three broad areas of ASD genomics:

(1) risk gene discovery and systems biology,

(2) functional analysis of variants associated with ASD risk genes and

(3) gene-targeted therapies. Successful proposals with a focus on the first two areas will likely involve large-scale analyses.

Funding: $200,000 to $400,000 per year 

Duration: 2-3 years

Research Authority due date: 29.6.21